10.200
−1,92%
2026-10-01
Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2.0% | +57.3% | 2 / 3 | +22.7% | +1.17 pp | -0.35 pp | +8.1% | 0.30 | 8.93 | 264 | +22,7% | 4,6 | +2,0% | 8.93 | 11.08 | −19,4% |
| Pts | 0 | 12 | 8 | 12 | 8 | 4 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 10.200 (close price on 2026-10-01)EPS (TTM): 1.142
Financial charts
1.Revenue & growth
VND bn264Q2/26
1.Revenue & growth
VND bn264Q2/26
2.Profit & growth
VND bn4,55Q2/26
3.Profit mix (Penman)
VND bn20,4Q2/26
4.Margins & cost structure
%8.9%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn-150Q2/26
7.Asset structure
VND bn742Q2/26
8.Funding & debt health
VND bn · times742Q2/26
9.Revenue backlog
VND bn238Q2/26
10.Valuation
times · %8,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %391Q2/26
Adjusted EPS growth, latest quarter
2.0%
Average adjusted EPS growth, 3 quarters
57.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26